DSM-Firmenich, CH1216478797

dsm-firmenich AG stock (CH1216478797): shares firm on Euronext Amsterdam as investors weigh valuation metrics

05.06.2026 - 21:36:36 | ad-hoc-news.de

dsm-firmenich AG shares on Euronext Amsterdam traded higher on 06/05/2026, with investors focusing on the Dutch group’s latest trading levels and valuation ratios after its recent integration phase.

DSM-Firmenich, CH1216478797
DSM-Firmenich, CH1216478797

dsm-firmenich AG shares traded at 68.40 EUR on 06/05/2026 on Euronext Amsterdam, according to Trivano as of 06/05/2026, reflecting a 6.81% gain on the day and putting the Dutch-listed stock back toward the upper half of its recent trading range.

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

  • Name: DSM-Firmenich
  • Sector/industry: Nutrition, health and beauty ingredients
  • Headquarters/country: Kaiseraugst, Switzerland and Maastricht, Netherlands
  • Core markets: Europe, North America, Asia-Pacific
  • Key revenue drivers: Nutrition, health, and fragrance ingredients for food, feed, personal care and pharma customers
  • Home exchange/listing venue: Euronext Amsterdam (DSFIR)
  • Trading currency: EUR

dsm-firmenich AG: core business model

dsm-firmenich AG operates as a global provider of specialty nutrition, health and fragrance solutions that serve food, feed, beauty, and pharmaceutical customers, with revenues driven largely by demand for value-added ingredients and formulation expertise across these end markets.

Valuation metrics and multiples for dsm-firmenich AG

With the stock at 68.40 EUR on 06/05/2026 on Euronext Amsterdam, according to Trivano as of 06/05/2026, investors are able to compare dsm-firmenich AG’s market value to its underlying earnings and cash flows, although detailed current-year earnings figures are not yet highlighted in the most recent public summaries.

Investing.com data for DSM-Firmenich as of 2025 pointed to a 2% increase in organic sales and a 10% rise in adjusted EBITDA for the third quarter of 2025, according to Investing.com as of 11/2025, which provides part of the backdrop for how the market currently assesses the company’s valuation profile versus its recent operating performance.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Sentiment and reactions on dsm-firmenich AG

The latest price move and valuation discussion for dsm-firmenich AG are also echoed in social and video commentary, where market participants debated the sustainability of the current trading level around Euronext Amsterdam.

YouTubeXTikTokInstagram

Conclusion

dsm-firmenich AG’s share price of 68.40 EUR on 06/05/2026 on Euronext Amsterdam positions the stock higher on the day, giving investors updated context for how the Dutch-listed nutrition and health ingredients group trades in the current market.

The latest available quarterly indicators from 2025, which showed low-single-digit organic sales growth and a double-digit percentage increase in adjusted EBITDA, according to Investing.com as of 11/2025, provide one reference point as investors analyze the valuation implied by the current share price without taking a view on future performance.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

So schätzen die Börsenprofis DSM-Firmenich Aktien ein!

<b>So schätzen die Börsenprofis DSM-Firmenich Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH1216478797 | DSM-FIRMENICH | boerse | 69489880 | bgmi